Trademarkia Logo

Australia

AU$
REXADEV
Registered: Registered/protected

Last updated on 8 Jun 2017

Owner Info

Amgen Inc.

One Amgen Center Drive

Thousand Oaks California 91320-1799, UNITED STATES OF AMERICA

Serial Number

1823520 filed on 2 Feb 2017

Correspondent

Herbert Smith Freehills

Level 24,,

80 Collins Street,

MELBOURNE, VIC, 3000 AUSTRALIA

REXADEV

Classification Information


Class [005]
Pharmaceutical preparations and biosimilars; pharmaceutical preparations, biosimilars and substances used for the treatment of bone, joint, intestine, Read More

Mark Details


Serial Number

1823520

Registered On

2 Feb 2017

Renewal On

2 Feb 2027

Mark Type

WORD

Priority Claim (Convention Details)


Date

22 Aug 2016

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Jun 2017IP Right Registration Published
31st May 2017Application Status
31st May 2017Register Trade Mark
23rd Mar 2017IP Right Acceptance Published
16th Mar 2017Application Accepted correspondence sent
16th Mar 2017Clear Examination report approved
16th Mar 2017User Created Notice correspondence sent
16th Feb 2017IP Right Filed Published
6th Feb 2017Application Status
6th Feb 2017Application Status